维眸生物向港交所提交上市申请

Group 1 - The core point of the article is that Weimou Biotechnology (Zhejiang) Co., Ltd. has submitted its listing application to the Hong Kong Stock Exchange on February 13, with China International Capital Corporation as the exclusive sponsor [1] Group 2 - The company is seeking to go public in Hong Kong, indicating a potential expansion and growth strategy [1] - The involvement of China International Capital Corporation suggests a strong backing and credibility for the listing process [1]